After a course of chemotherapy, ALDH+, CD117+Axl+, CD117+Axl+EGF+CD44+, CD117+EGF+, and EGF+Axl+ were slightly decreased, which corresponded to the general trend found in the general group of examined patients with SCLC. The gene discussed is AXL; the disease is small cell lung carcinoma.